Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 17. Januar 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8763  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 175260  
   
Risk-Stratified Gleason Upgrading in ISUP Grade Group 1 Prostate Cancer: Combined Analysis of TMPRSS2-ERG, PTEN, Ki-67, and MRI-Derived Apparent Diffusion Coefficient Values.
Int J Urol
Alkan Vur, , Vur, Ya, Çelen S, Duran MB.
PMID: 41545857 [PubMed - indexed for MEDLINE]


Circulating tumour cells as a window into lethality in prostate cancer.
Nat Rev Urol
Abusamra SM, Anbarasan T, Cotton DT, Ranasinha NMS, Barber R, Bridge S, Smith C, Figiel S, Yin W, Davis JJ, Salami SS, Hamdy FC, Bryant RJ, Lu YJ, Mills IG, Edwards CM, Morgan TM, Lamb AD.
PMID: 41545704 [PubMed - as supplied by publisher]


Regulation of androgen receptor expression by enhancer elements in prostate cancer.
Exp Mol Med
Khadka S, Jeon HY, Hussain A, Qi J.
PMID: 41545686 [PubMed - as supplied by publisher]


Tumor Laterality Predicts Pelvic Lymph Node Metastasis Patterns in Bladder Cancer.
Ann Surg Oncol
Hajime T, Shiota M, Fukuchi G, Mutaguchi J, Matsumoto T, Tanegashima T, Tsukahara S, Kobayashi S, Eto M.
PMID: 41545612 [PubMed - as supplied by publisher]


Robot-Assisted Radical Cystectomy in the Very Elderly: A Propensity Score-Matched Comparison of Outcomes Between Patients Aged ≥ 85 Versus 75-84 Years.
Geriatr Gerontol Int
Sasaki Y, Izumi K, Fukuta K, Kadoriku F, Daizumoto K, Shiozaki K, Fukawa T, Yanagihara Y, Izaki H, Okamoto K, Yamanaka M, Furukawa J.
PMID: 41545013 [PubMed - indexed for MEDLINE]


ctDNA-Guided Immunotherapy following Radical Cystectomy for Muscle-Invasive Bladder Cancer: Results from the TOMBOLA Trial.
Ann Oncol
Dyrskjøt L, Birkenkamp-Demtröder K, Nordentoft I, Strandgaard T, Lindskrog SV, Milling RV, Körner SK, Brandt SB, Knudsen M, Andreasen TG, Hansen CF, Lamy P, Lam G, Dohn LH, Fabrin K, Carus A, Petersen AC, Joensen UN, Pappot H, Holt PS, Jensen NV, Agerbæk M, Jensen JB.
PMID: 41544704 [PubMed - as supplied by publisher]


Recent advances and future prospects of immunotherapeutic approaches in prostate cancer.
J Transl Med
Wang N, Wang C, Cui S, Zhao K, Zhang J, Zhang L, Jia Y, Kong F.
PMID: 41546087 [PubMed - as supplied by publisher]


From mechanisms to therapy: the role of tertiary lymphoid structures in bladder cancer.
World J Surg Oncol
Yang J, Li X, Xie H, Guo J, Wang J, Lin C.
PMID: 41545849 [PubMed - as supplied by publisher]


Small-molecule modulators of the androgen receptor N-terminal domain: Advances in medicinal chemistry for prostate cancer.
Eur J Med Chem
Sekhon I, Ashong D, Chen G, Chen QH.
PMID: 41544581 [PubMed - as supplied by publisher]


Using Latent Dirichlet Allocation Topic Modeling to Uncover Latent Research Topics and Trends in Renal Cell Carcinoma: Bibliometric Review.
JMIR Cancer
De La Hoz-M J, Montes-Escobar K, Salas-Macias CA, Fors M, Ballaz SJ.
PMID: 41544251 [PubMed - indexed for MEDLINE]


Docetaxel Rechallenge vs Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer.
JAMA Netw Open
Barata PC, Corrigan JK, La J, Culnan JM, Akama-Garren E, Dulberger KN, Dumontier C, Hansen J, Bihn JR, Bitting RL, Brophy MT, Cheng HH, Cooperberg MR, Do NV, Dorff T, Fojo AT, Gaziano JM, Goryachev SD, Halabi S, Hauger RL, Nanus DM, Rebbeck TR, Pan CX, Schoen MW, Swinnerton KN, Myrie K, Ramoni RB, Fillmore NR, Paller CJ, Rettig MB.
PMID: 41543856 [PubMed - indexed for MEDLINE]


(18)F-PSMA-PET/CT in comparison with whole-body MRI and combination of conventional CT and bone scintigraphy for detection of recurrent disease in prostate cancer patients with rising PSA levels after initial definitive treatment.
Int J Clin Oncol
Murata S, Moribata Y, Akamatsu S, Kido A, Himoto Y, Kurata Y, Otani T, Sumiyoshi T, Saito R, Ogata T, Aizawa R, Nakamura K, Mizowaki T, Nakamoto Y, Kobayashi T, Goto T.
PMID: 41543807 [PubMed - as supplied by publisher]


Immunotherapy in clear cell renal cell carcinoma: current Status, novel Strategies, and future perspectives.
Clin Exp Med
Chen X, Ke Y, Huang X, Chen J, Chen J, Chen Z.
PMID: 41543784 [PubMed - as supplied by publisher]


Predictive factors for negative prostate biopsy in PI-RADS 5 patients: a multivariate analysis of clinical and imaging-based factors.
World J Urol
Acevedo C, Arroyave JS, López L, Saldivia D, Singhal M, Moya F, Sánchez C, Larenas F.
PMID: 41543542 [PubMed - indexed for MEDLINE]


Bayesian reanalysis to assess consistency of TALAPRO-2 results in the Japanese subgroup with metastatic castration-resistant prostate cancer.
Jpn J Clin Oncol
Hirose K, Yoshida S, Chen W, Yajima S, Hirakawa A, Tanabe K, Fujiwara M, Fukushima H, Yasuda Y, Tanaka H, Masuda H, Fujii Y.
PMID: 41543049 [PubMed - as supplied by publisher]


Age-stratified outcomes of radical cystectomy for muscle-invasive bladder cancer: a nationwide multicenter study of 1867 patients in Japan.
Jpn J Clin Oncol
Kawai T, Miki J, Taoka R, Saito R, Fukuokaya W, Matsui Y, Fujii Y, Hatakeyama S, Kawahara T, Matsuda A, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Nakayama M, Matsumoto T, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Kobayashi K, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Kume H, Japan Urological Oncology Group.
PMID: 41543041 [PubMed - as supplied by publisher]


Pitfalls and Limitations of the Vesical Imaging-Reporting and Data System (VI-RADS): Challenges in the Multiparametric Magnetic Resonance Imaging (mpMRI) Assessment of Bladder Cancer.
Cureus
Laert J, Lupi Manso N, França de Santana T, Santos PO.
PMID: 41541939 [PubMed]


Best evidence summary on gastrointestinal function recovery after radical cystectomy for bladder cancer.
Asia Pac J Oncol Nurs
Dai Y, Zhang X, Lin Q, Gu X.
PMID: 41541189 [PubMed]


Survival for Children Diagnosed With Wilms Tumour (2012-2022) Registered in the UK and Ireland Improving Population Outcomes for Renal Tumours of Childhood (IMPORT) Study.
Pediatr Blood Cancer
Ssenyonga N, Lopez-Cortes A, Al-Saadi R, Tugnait S, Dzhuma K, Duncan C, Vujanic G, Chowdhury T, Allemani C, Coleman MP, Pritchard-Jones K, Children's Cancer and Leukaemia Group (CCLG) Renal Tumour Special Interest Group.
PMID: 41540889 [PubMed - as supplied by publisher]


Clinical, Cytologic, Histopathologic, and Diagnostic Imaging of a Malignant Peripheral Nerve Sheath Tumor in the Renal Pelvis of a Border Collie Dog.
Vet Clin Pathol
Romero-Vélez F, Serrano B, Martínez-Caro J, González-Rellán S, Novellas R, García-Ferrer A, Pastor J, Solano-Gallego L.
PMID: 41540823 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 175260    Seite 1 von 8763  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1